Breaking the Glass Ceiling: Low eGFR in the Use of MRA Therapy
- PMID: 36328656
- DOI: 10.1016/j.jchf.2022.08.017
Breaking the Glass Ceiling: Low eGFR in the Use of MRA Therapy
Keywords: chronic kidney disease; finerenone; heart failure; type 2 diabetes.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.JACC Heart Fail. 2022 Nov;10(11):860-870. doi: 10.1016/j.jchf.2022.07.013. Epub 2022 Oct 12. JACC Heart Fail. 2022. PMID: 36328655 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
